Novel Drug Prevents Common Viral Disease in Stem-Cell Transplant Patients Science Daily (press release) Sep. 25, 2013 — A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's ... Chimerix Announces Publication of Positive Phase 2 Results of Brincidofovir ... Cytomegalovirus—a 'stealth' pathogen—gains attention in the drug development ... CMX001 reduced cytomegalovirus disease after HSCT |
